Nanologica AB (publ)'s latest marketcap:
As of 07/17/2026, Nanologica AB (publ)'s market capitalization has reached $16.29 M. According to our data, Nanologica AB (publ) is the 39073th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 16.29 M |
| Revenue (ttm) | 3.29 M |
| Net Income (ttm) | 2.49 M |
| Shares Out | 328.77 M |
| EPS (ttm) | 0.03 |
| Forward PE | 9.58 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/27/2026 |
Nanologica AB (publ)'s yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/17/2026 | kr157.48 M | $16.29 M | 185.23% | 39073 |
| 12/30/2025 | kr68.93 M | $7.29 M | -57.14% | 37885 |
| 12/30/2024 | kr160.81 M | $14.46 M | -57.22% | 36134 |
| 12/29/2023 | kr375.92 M | $37.07 M | 33.47% | 29817 |
| 12/30/2022 | kr281.66 M | $26.87 M | -27.01% | 30948 |
| 12/30/2021 | kr385.87 M | $42.45 M | 3.67% | 28541 |
| 12/30/2020 | kr372.21 M | $0 | 113.3% | 25319 |
| 12/30/2019 | kr174.5 M | $18.55 M | 230.19% | 26681 |
| 12/28/2018 | kr52.85 M | $5.94 M | 27.88% | 29309 |
| 12/29/2017 | kr41.33 M | $5.03 M | -43.81% | 29101 |
Company Profile
About Nanologica AB (publ)
Nanologica AB (publ) is a nanotechnology company specializing in the development, manufacturing, and sale of nanoporous silica particles for life science applications worldwide.
Business Segments
- Drug Development – Focused on innovative solutions for life science applications.
- Chromatography – Offers advanced silica-based products for substance analysis and purification.
Key Products
- NLAB Saga – A next-generation silica for preparative chromatography.
- SVEA HPLC Analytical Columns – Designed for high-performance liquid chromatography.
Applications
The company's products are primarily used in the analysis and purification of substances, with a strong focus on peptides and diabetes drugs.
Innovation & Development
Nanologica is actively developing Nanoporous Amorphous Particles (NAP), a platform technology for inhalation therapies aimed at improving treatments for severe lung diseases.
Company Background
Founded in 2004, Nanologica AB (publ) is headquartered in Södertälje, Sweden.
Frequently Asked Questions
-
What is Nanologica AB (publ)'s (STO-NICA) current market cap?As of 07/17/2026, Nanologica AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $16.29 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nanologica AB (publ) (STO-NICA) rank globally by market cap?Nanologica AB (publ) global market capitalization ranking is approximately 39073 as of 07/17/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.